June 30, 2020
Fact Sheet: MMAPPP Act Fact Sheet
The federal government has spent tens of billions of taxpayer dollars on research and development (R&D) of vaccines and treatments for COVID-19, including $23 billion for manufacturing and purchasing. Despite this public investment, there is no guarantee that these taxpayer-funded drugs will be affordable, accessible, or available to all those who need them.
To address this issue, Representatives Jan Schakowsky (D-IL) and Francis Rooney (R-FL) introduced the Make Medications Affordable by Preventing Pandemic Price Gouging Act, H.R. 7296, on June 17, 2020.
Download the fact sheet.